Back to DE Deerfield Management Company, L.P.

BCRXBCRX

Showing 8 of 26 quarters

Position history for DEDeerfield Management Company, L.P.'s holdings in BioCryst Pharmaceuticals, Inc.

Yes. Deerfield Management holds 15,490,928 shares of BCRX, worth $129M, as of its Q3 2026 13F filing. It increased the position by 394,525 shares (+2.6%) from Q2 2026. Deerfield Management has held BCRX since Q1 2023, across 15 quarterly 13F filings. BCRX is 2.0% of Deerfield Management's reported 13F portfolio.

Current Value

$129M

Current Shares

15.5M

Total Value Change

+$67.8M

Total Shares Change

+7.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
15.5M
+2.6%
$129M2.0%$8.33
49
2026-Q2
Increased
15.1M
+0.4%
$151M1.6%$10.00
48
2026-Q1
Increased
15M
+4.9%
$143.2M1.7%$9.52
50
2025-Q4
Increased
14.3M
+17.9%
$111.9M1.4%$7.80
55
2025-Q3
Increased
12.2M
+159.4%
$92.4M1.4%$7.59
76
2025-Q2
Decreased
4.7M
-9.6%
$42M0.8%$8.96
0
2025-Q1
Decreased
5.2M
-36.3%
$38.9M0.8%$7.50
0
2024-Q4
Increased
8.1M
+0.1%
$61.2M1.2%$7.52
46

Optional analytics helps us improve. How it’s used